Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The cell membrane and proton gradient of cariogenic oral bacteria, most notably Streptococcus mutans, represent a fundamental physiological target for anti-caries therapy (PubMed: 11705156). These bacteria survive the acidic environment of dental plaque by maintaining a transmembrane pH gradient, primarily through the action of a proton-translocating F-ATPase that actively pumps protons out of the cytoplasm (PubMed: 16171344). This gradient, known as the proton motive force, is essential for driving ATP synthesis and the secondary transport of nutrients required for bacterial growth and biofilm formation. Therapeutic interventions such as fluoride ions directly inhibit F-ATPase and facilitate the transport of protons back into the cell as hydrogen fluoride, thereby collapsing the gradient and inhibiting bacterial metabolism (NIH: PMC281238). Other antimicrobial agents like chlorhexidine and cetylpyridinium chloride target the bacterial cell membrane directly, increasing its permeability and leading to the loss of cellular homeostasis and eventual cell death (PubMed: 12673917). Targeting these systems effectively reduces the acidogenic potential of the oral biofilm, which is the primary driver of dental enamel demineralization and caries progression.
The primary mechanism involves the inhibition of the proton-translocating F-ATPase (F1F0-ATPase), which prevents the extrusion of protons and leads to intracellular acidification (PubMed: 16171344). Additionally, agents like chlorhexidine disrupt the structural integrity of the bacterial cell membrane, causing the leakage of essential ions and metabolites and the dissipation of the proton motive force (PubMed: 12673917).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cariogenic oral bacterial cell membrane and proton gradient.